60 related articles for article (PubMed ID: 16093558)
1. Evaluation of the InteraX system technology in a high-throughput screening environment.
Büttner FH; Kumpf R; Menzel S; Reulle D; Valler MJ
J Biomol Screen; 2005 Aug; 10(5):485-94. PubMed ID: 16093558
[TBL] [Abstract][Full Text] [Related]
2. Identification of iNOS inhibitors using InteraX.
Mallinder PR; Wallace AV; Allenby G
J Biomol Screen; 2009 Mar; 14(3):263-72. PubMed ID: 19211775
[TBL] [Abstract][Full Text] [Related]
3. Application of beta-galactosidase enzyme complementation technology as a high throughput screening format for antagonists of the epidermal growth factor receptor.
Graham DL; Bevan N; Lowe PN; Palmer M; Rees S
J Biomol Screen; 2001 Dec; 6(6):401-11. PubMed ID: 11788058
[TBL] [Abstract][Full Text] [Related]
4. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
5. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor dimerization monitored in live cells.
Blakely BT; Rossi FM; Tillotson B; Palmer M; Estelles A; Blau HM
Nat Biotechnol; 2000 Feb; 18(2):218-22. PubMed ID: 10657132
[TBL] [Abstract][Full Text] [Related]
7. A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors.
Lin WH; Song JS; Chang TY; Chang CY; Fu YN; Yeh CL; Wu SH; Huang YW; Fang MY; Lien TW; Hsieh HP; Chao YS; Huang SF; Tsai SF; Wang LM; Hsu JT; Chen YR
Anal Biochem; 2008 Jun; 377(1):89-94. PubMed ID: 18358823
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of division-arrested cells for cell-based high-throughput screening and profiling.
Digan ME; Pou C; Niu H; Zhang JH
J Biomol Screen; 2005 Sep; 10(6):615-23. PubMed ID: 16103416
[TBL] [Abstract][Full Text] [Related]
9. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW
Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592
[TBL] [Abstract][Full Text] [Related]
10. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
12. Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABA(A) receptor.
Joesch C; Guevarra E; Parel SP; Bergner A; Zbinden P; Konrad D; Albrecht H
J Biomol Screen; 2008 Mar; 13(3):218-28. PubMed ID: 18270364
[TBL] [Abstract][Full Text] [Related]
13. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase.
Brandish PE; Chiu CS; Schneeweis J; Brandon NJ; Leech CL; Kornienko O; Scolnick EM; Strulovici B; Zheng W
J Biomol Screen; 2006 Aug; 11(5):481-7. PubMed ID: 16760370
[TBL] [Abstract][Full Text] [Related]
14. Feasibility evaluation of 3 automated cellular drug screening assays on a robotic workstation.
Soikkeli A; Sempio C; Kaukonen AM; Urtti A; Hirvonen J; Yliperttula M
J Biomol Screen; 2010 Jan; 15(1):30-41. PubMed ID: 19940082
[TBL] [Abstract][Full Text] [Related]
15. Beta galactosidase enzyme fragment complementation as a high-throughput screening protease technology.
Naqvi T; Lim A; Rouhani R; Singh R; Eglen RM
J Biomol Screen; 2004 Aug; 9(5):398-408. PubMed ID: 15296639
[TBL] [Abstract][Full Text] [Related]
16. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability.
Wu X; Sills MA; Zhang JH
J Biomol Screen; 2005 Sep; 10(6):581-9. PubMed ID: 16103421
[TBL] [Abstract][Full Text] [Related]
17. A mammalian genetic system to screen for small molecules capable of disrupting protein-protein interactions.
Zhao HF; Kiyota T; Chowdhury S; Purisima E; Banville D; Konishi Y; Shen SH
Anal Chem; 2004 May; 76(10):2922-7. PubMed ID: 15144206
[TBL] [Abstract][Full Text] [Related]
18. Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors.
Lee HK; Brown SJ; Rosen H; Tobias PS
Mol Pharmacol; 2007 Oct; 72(4):868-75. PubMed ID: 17615244
[TBL] [Abstract][Full Text] [Related]
19. Statistical analysis of systematic errors in high-throughput screening.
Kevorkov D; Makarenkov V
J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
[TBL] [Abstract][Full Text] [Related]
20. Statistical and graphical methods for quality control determination of high-throughput screening data.
Gunter B; Brideau C; Pikounis B; Liaw A
J Biomol Screen; 2003 Dec; 8(6):624-33. PubMed ID: 14711388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
